| Convergent antibody responses to SARS-CoV-2 in convalescent individuals DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ... Nature 584 (7821), 437-442, 2020 | 1983 | 2020 |
| Evolution of antibody immunity to SARS-CoV-2 C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... Nature 591 (7851), 639-644, 2021 | 1685 | 2021 |
| mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ... Nature 592 (7855), 616-622, 2021 | 1485 | 2021 |
| Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ... elife 9, e61312, 2020 | 1469 | 2020 |
| Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection Z Wang, F Muecksch, D Schaefer-Babajew, S Finkin, C Viant, C Gaebler, ... Nature 595 (7867), 426-431, 2021 | 733 | 2021 |
| Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ... Journal of Experimental Medicine 217 (11), e20201181, 2020 | 559 | 2020 |
| Plasma neutralization of the SARS-CoV-2 Omicron variant F Schmidt, F Muecksch, Y Weisblum, J Da Silva, E Bednarski, A Cho, ... New England Journal of Medicine 386 (6), 599-601, 2022 | 457 | 2022 |
| Enhanced SARS-CoV-2 neutralization by dimeric IgA Z Wang, JCC Lorenzi, F Muecksch, S Finkin, C Viant, C Gaebler, ... Science translational medicine 13 (577), eabf1555, 2021 | 450* | 2021 |
| Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies AJ Greaney, TN Starr, CO Barnes, Y Weisblum, F Schmidt, M Caskey, ... Nature communications 12 (1), 4196, 2021 | 399* | 2021 |
| Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ... Immunity 54 (8), 1853-1868. e7, 2021 | 289* | 2021 |
| Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination A Cho, F Muecksch, D Schaefer-Babajew, Z Wang, S Finkin, C Gaebler, ... Nature 600 (7889), 517-522, 2021 | 265 | 2021 |
| Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost F Muecksch, Z Wang, A Cho, C Gaebler, T Ben Tanfous, J DaSilva, ... Nature 607 (7917), 128-134, 2022 | 237* | 2022 |
| MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation R Wu, J Zeng, J Yuan, X Deng, Y Huang, L Chen, P Zhang, H Feng, Z Liu, ... The Journal of clinical investigation 128 (6), 2551-2568, 2018 | 217 | 2018 |
| Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants J Xu, K Xu, S Jung, A Conte, J Lieberman, F Muecksch, JCC Lorenzi, ... Nature 595 (7866), 278-282, 2021 | 186 | 2021 |
| Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques A Escolano, HB Gristick, ME Abernathy, J Merkenschlager, R Gautam, ... Nature 570 (7762), 468-473, 2019 | 153 | 2019 |
| IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation M Zhao, Y Tan, Q Peng, C Huang, Y Guo, G Liang, B Zhu, Y Huang, A Liu, ... Nature communications 9 (1), 583, 2018 | 109 | 2018 |
| T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis X Liu, W Zhang, M Zhao, L Fu, L Liu, J Wu, S Luo, L Wang, Z Wang, L Lin, ... Annals of the rheumatic diseases 78 (8), 1070-1078, 2019 | 105 | 2019 |
| Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins Z Wang, F Muecksch, A Cho, C Gaebler, HH Hoffmann, V Ramos, S Zong, ... Immunity 55 (6), 998-1012. e8, 2022 | 97* | 2022 |
| Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials Y Deng, Z Wang, C Chang, L Lu, CS Lau, Q Lu Human immunology 78 (2), 120-128, 2017 | 96 | 2017 |
| Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination D Schaefer-Babajew, Z Wang, F Muecksch, A Cho, M Loewe, M Cipolla, ... Nature 613 (7945), 735-742, 2023 | 67* | 2023 |
